欧洲呼吸学会(ERS)第20届年会。

Idrugs Pub Date : 2010-11-01

John Paul Seale

{"title":"欧洲呼吸学会(ERS)第20届年会。","authors":"John Paul Seale","doi":"","DOIUrl":null,"url":null,"abstract":"The European Respiratory Society Congress, held in Barcelona, included topics covering new therapeutic developments in the field of respiratory health and disease. This conference report highlights selected presentations on therapies targeting inflammatory cells, with a focus on therapeutic agents for asthma and COPD. This report also includes a discussion of novel therapeutic agents for pulmonary hypertension. Investigational drugs discussed include OC-000459 (Oxagen), SCH-527123 (Merck & Co), AZD-9668 (AstraZeneca), benralizumab (MedImmune/Kyowa Hakko Kirin/BioWa), PF-3429281 (Pfizer), vilanterol (GlaxoSmithKline/Theravance), LAS-100977 (Almirall Prodesfarma), selexipag (Nippon Shinyaku/Actelion) and GW-0742 (GlaxoSmithKline).","PeriodicalId":55031,"journal":{"name":"Idrugs","volume":"13 11","pages":"762-4"},"PeriodicalIF":0.0000,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"European Respiratory Society (ERS) - 20th Annual Congress.\",\"authors\":\"John Paul Seale\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The European Respiratory Society Congress, held in Barcelona, included topics covering new therapeutic developments in the field of respiratory health and disease. This conference report highlights selected presentations on therapies targeting inflammatory cells, with a focus on therapeutic agents for asthma and COPD. This report also includes a discussion of novel therapeutic agents for pulmonary hypertension. Investigational drugs discussed include OC-000459 (Oxagen), SCH-527123 (Merck & Co), AZD-9668 (AstraZeneca), benralizumab (MedImmune/Kyowa Hakko Kirin/BioWa), PF-3429281 (Pfizer), vilanterol (GlaxoSmithKline/Theravance), LAS-100977 (Almirall Prodesfarma), selexipag (Nippon Shinyaku/Actelion) and GW-0742 (GlaxoSmithKline).\",\"PeriodicalId\":55031,\"journal\":{\"name\":\"Idrugs\",\"volume\":\"13 11\",\"pages\":\"762-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Idrugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Idrugs","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

在巴塞罗那举行的欧洲呼吸学会大会的主题包括呼吸健康和疾病领域的新治疗发展。本次会议报告重点介绍了针对炎症细胞的治疗方法，重点是哮喘和慢性阻塞性肺病的治疗药物。本报告还讨论了治疗肺动脉高压的新药物。讨论的研究药物包括OC-000459 (Oxagen)、schh -527123 (Merck & Co)、AZD-9668 (AstraZeneca)、benralizumab (MedImmune/Kyowa Hakko Kirin/BioWa)、PF-3429281(辉瑞)、vilanterol(葛兰素史克/Theravance)、as -100977 (Almirall Prodesfarma)、selexipag (Nippon Shinyaku/Actelion)和GW-0742(葛兰素史克)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

European Respiratory Society (ERS) - 20th Annual Congress.

The European Respiratory Society Congress, held in Barcelona, included topics covering new therapeutic developments in the field of respiratory health and disease. This conference report highlights selected presentations on therapies targeting inflammatory cells, with a focus on therapeutic agents for asthma and COPD. This report also includes a discussion of novel therapeutic agents for pulmonary hypertension. Investigational drugs discussed include OC-000459 (Oxagen), SCH-527123 (Merck & Co), AZD-9668 (AstraZeneca), benralizumab (MedImmune/Kyowa Hakko Kirin/BioWa), PF-3429281 (Pfizer), vilanterol (GlaxoSmithKline/Theravance), LAS-100977 (Almirall Prodesfarma), selexipag (Nippon Shinyaku/Actelion) and GW-0742 (GlaxoSmithKline).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Idrugs 医学-药学

自引率

0.00%

发文量

审稿时长

>12 weeks